Moluzaq contains Molnupiravir 200mg, an oral antiviral medicine developed to treat mild to moderate COVID-19 in adults at risk of developing severe illness.
| Generic Name | Molnupiravir |
| Manufacturer | Astraea Life Sciences Pvt Ltd |
| Packing | 40 Capsules |
| Prescribed For | (COVID-19) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
